Based on analysis of TCGA database, high expression of RACGAP1 is significantly associated with breast cancer, lung adenocarcinoma, papillary renal cell carcinoma, hepatocellular carcinoma and cutaneous melanoma. Here, RACGAP1 is linked to breast carcinoma.